Gynecologic cytology is used for the early detection of precursor stages of cervical cancer. Diagnoses are reported based on the Bethesda System or the Papanicolaou classification. Upon request, the Munich Nomenclature III or combinations of different systems can also be used.
If required, PCR-based tests can be performed simultaneously or subsequently within one month of the sample being LBC-fixed on residual cellular material to screen for HPV, chlamydia, HSV-1/HSV-2, and gonococcal infections.
If desired, immunocytochemical staining with CINtecPLUS can be performed to identify transforming high-risk HPV infections.